Minute 6. Working Group on Group A streptococci. It was agreed that members of the present Working Group on Group A streptococci, consisting of Dr. Rotta, Dr. Facklam, Dr. Maxted, Dr. Kohler, Dr. Rabinowitz, Dr. Miyamoto, and Dr. Kjems, assume responsibility for revising the system for recognition and designation of new M-types. Dr. Maxted will s e r e as Chairman of the Working Group. Dr. Rotta was requested to be responsible for assigning M-type numbers when appropriate criteria have been met. He will receive and coordinate information, cultures, and antisera and arrange for laboratory validation studies on proposed new Mtypes. The Subcommittee unanimously expressed the view that this activity is more appropriately a function that should be served by the World Health Organization (W.H.O.) International Streptococcal Typing Center in Prague. Dr. Rotta is Director of the Center. The large amount of time and work required by the Reference Center may require additional funds that are not presently budgeted. Because of the importance of maintaining an officially sponsored mechanism for an orderly system for serotype recognition of group A streptococci in epidemiological studies on streptococcal diseases and their sequelae, the Subcommittee unanimously recommended that the W.H.O. be urged to appropriate the necessary funds and sponsor the activity. Such an activity would also strengthen the quality of laboratory work performed in Regional W.H.O. Streptococcal Reference Laboratories. Dr. Facklam was requested to draft a proposal for a system, whereby criteria and procedures for acceptance of new designations for M-types would be clarified. The proposal will include careful consideration of difficulties experienced under the present system, as well as new data that have been developed from newer methodologies. It was suggested that additional laboratories be designated for examining candidate strains for new M-type designation. 
